Mironid strengthens Board and clinical team to support next phase of growth
Dr. Omar Khwaja joins the Board as Non-Executive DirectorSenior leadership team further strengthened with the appointments of Lars Erwig and...
Dr. Omar Khwaja joins the Board as Non-Executive DirectorSenior leadership team further strengthened with the appointments of Lars Erwig and...
Company announcement – No. 56 / 2026 Zealand Pharma Announces Financial Results for the First Nine Months of 2026Advancing at...
Pratteln, Switzerland, November 12, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces it has signed an exclusive agreement with SteinCares for...
The New York medical billing company details the outsourcing medical billing services it is built around, what each one delivers,...
LONG BEACH, Calif. and TORONTO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company")...
BEDMINSTER, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today...
In a release issued under the same headline earlier today by Milestone Scientific, Inc., please note that in the first...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 11, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN),...
PHILADELPHIA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset...
REYKJAVIK, Iceland, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company...
REYKJAVIK, ICELAND (November 11, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in...
ROSELAND, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery...
MIAMI, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for...
Record quarterly revenue of $2.3 million, representing approximately 28% year-over-year growth, reflecting continued adoption of first-generation LungFit PH PMA supplement...
Acquired Advanced Vision Science, Inc. (AVS), securing scalable commercial intraocular lens (IOL) manufacturing capacity for its Phase 3 lead product...
Continued adoption of the QUELIMMUNE® therapy yielded 247% increase in net revenue compared to the third quarter of 2025 Achieved...
Top-line results for SLIM-1™, the first-in-human Phase 1 trial of NPM-139, Vivani's miniature, ultra-long-acting semaglutide implant under development for chronic...
Pelareorep and toripalimab combine potentially complementary mechanisms designed to enhance antitumor immune responses and help overcome tumor immune resistance Study...
NOVATO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Amlogenyx, Inc., a biotechnology company focused on developing gene therapies for Alzheimer’s...
LONDON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a...